Follow this preprint
Anti-inflammatory SARS-CoV-2 T cell immunity in asymptomatic seronegative Kenyan adults
View ORCID ProfileTaraz Samandari, Joshua Ongalo, Kim McCarthy, Richard K. Biegon, Philister Madiega, Anne Mithika, Joseph Orinda, Grace M. Mboya, Patrick Mwaura, Omu Anzala, Clayton Onyango, Fredrick O. Oluoch, Eric Osoro, Charles-Antoine Dutertre, Nicole Tan, Shou Kit Hang, Smrithi Hariharaputran, David C Lye, Amy Herman-Roloff, Nina Le Bert, View ORCID ProfileAntonio Bertoletti
doi: https://doi.org/10.1101/2023.02.17.23286075
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Taraz Samandari
1U.S. Centers for Disease Control & Prevention, Kenya
Joshua Ongalo
2Kenya Medical Research Institute, Centre for Global Health Research, Kisumu, Kenya
Kim McCarthy
1U.S. Centers for Disease Control & Prevention, Kenya
Richard K. Biegon
3Moi University School of Medicine, Immunology Section, Eldoret, Kenya
Philister Madiega
2Kenya Medical Research Institute, Centre for Global Health Research, Kisumu, Kenya
Anne Mithika
2Kenya Medical Research Institute, Centre for Global Health Research, Kisumu, Kenya
Joseph Orinda
2Kenya Medical Research Institute, Centre for Global Health Research, Kisumu, Kenya
Grace M. Mboya
2Kenya Medical Research Institute, Centre for Global Health Research, Kisumu, Kenya
Patrick Mwaura
4KAVI Institute of Research, University of Nairobi, Nairobi, Kenya
Omu Anzala
4KAVI Institute of Research, University of Nairobi, Nairobi, Kenya
Clayton Onyango
1U.S. Centers for Disease Control & Prevention, Kenya
Fredrick O. Oluoch
5County Government of Kisumu, Department of Health & Sanitation, Kisumu, Kenya
Eric Osoro
6Washington State University Global Health Kenya, Nairobi, Kenya
7Paul G. Allen School of Global Health, Washington State University, Pullman, USA
Charles-Antoine Dutertre
8Gustave Roussy Cancer Campus, Villejuif, France
9Institut National de la Santé et de la Recherche Médicale (INSERM) U1015, Equipe Labellisée—Ligue Nationale contre le Cancer, Villejuif, France
Nicole Tan
10Programme in Emerging Infectious Diseases, Duke University-National University of Singapore Medical School, Singapore
Shou Kit Hang
10Programme in Emerging Infectious Diseases, Duke University-National University of Singapore Medical School, Singapore
Smrithi Hariharaputran
10Programme in Emerging Infectious Diseases, Duke University-National University of Singapore Medical School, Singapore
David C Lye
11National Centre for Infectious Diseases, Singapore
12Tan Tock Seng Hospital, Singapore
13Yong Loo Lin School of Medicine, National University of Singapore, Singapore
14Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore
Amy Herman-Roloff
1U.S. Centers for Disease Control & Prevention, Kenya
Nina Le Bert
10Programme in Emerging Infectious Diseases, Duke University-National University of Singapore Medical School, Singapore
Antonio Bertoletti
10Programme in Emerging Infectious Diseases, Duke University-National University of Singapore Medical School, Singapore
15Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore

Data Availability
Data produced in the present study are available upon reasonable request to the authors
Posted February 18, 2023.
Anti-inflammatory SARS-CoV-2 T cell immunity in asymptomatic seronegative Kenyan adults
Taraz Samandari, Joshua Ongalo, Kim McCarthy, Richard K. Biegon, Philister Madiega, Anne Mithika, Joseph Orinda, Grace M. Mboya, Patrick Mwaura, Omu Anzala, Clayton Onyango, Fredrick O. Oluoch, Eric Osoro, Charles-Antoine Dutertre, Nicole Tan, Shou Kit Hang, Smrithi Hariharaputran, David C Lye, Amy Herman-Roloff, Nina Le Bert, Antonio Bertoletti
medRxiv 2023.02.17.23286075; doi: https://doi.org/10.1101/2023.02.17.23286075
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (410)
- Allergy and Immunology (725)
- Anesthesia (214)
- Cardiovascular Medicine (3083)
- Dermatology (260)
- Emergency Medicine (462)
- Epidemiology (13010)
- Forensic Medicine (13)
- Gastroenterology (859)
- Genetic and Genomic Medicine (4827)
- Geriatric Medicine (444)
- Health Economics (750)
- Health Informatics (3052)
- Health Policy (1101)
- Hematology (406)
- HIV/AIDS (955)
- Medical Education (453)
- Medical Ethics (119)
- Nephrology (499)
- Neurology (4596)
- Nursing (244)
- Nutrition (682)
- Oncology (2383)
- Ophthalmology (673)
- Orthopedics (268)
- Otolaryngology (333)
- Pain Medicine (300)
- Palliative Medicine (87)
- Pathology (514)
- Pediatrics (1237)
- Primary Care Research (519)
- Public and Global Health (7183)
- Radiology and Imaging (1598)
- Respiratory Medicine (943)
- Rheumatology (459)
- Sports Medicine (402)
- Surgery (508)
- Toxicology (65)
- Transplantation (220)
- Urology (188)